EPS

EPS

West Pharmaceutical ups FY24 adjusted EPS view to $6.55-$6.75 from $6.35-$6.65

By [Your Name] In a significant move that has sent ripples through the pharmaceutical industry, West Pharmaceutical Services, Inc. (WST) has announced an upward revision of its fiscal year 2024 (FY24) adjusted earnings per share (EPS) guidance. The company now expects to achieve an adjusteddiluted EPS in the range of $6.55 to $6.75, up from its previous forecast of $6.35 to $6.65..

EPS

West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend

Executive Summary West Pharmaceutical Services, Inc..